Patient‐ and system‐level factors associated with racial/ethnic disparities in the delivery of guideline‐concordant therapy among US patients with gastric cancer
Journal of Surgical Oncology · 2024-06 · 129 (8) · 1542-1553
DOI: 10.1002/jso.27683 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of Surgical Oncology, online erschienen am 16.05.2024. Verfasst von Wilson L da Costa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Section of Epidemiology and Population Sciences, Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: Stomach Neoplasms, Healthcare Disparities. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, Research Training Awards from the Cancer Prevention & Research Institute of Texas for the Cancer Prevention Post-Graduate Training Program in Integrative Epide…, Systems Epidemiology of Cancer Training Program (SECT).
Abstract (Originalsprache)
Background
Disparities in gastric cancer (GC) outcomes show a higher disease burden among minorities. We aimed to evaluate the associations between sociodemographic and system‐level factors and guideline‐concordant treatment among GC patients.
Methods
Cohort study with GC patients in the National Cancer Data Base (2006–2018) treated with upfront resection or neoadjuvant therapy (NAT). We used logistic regression to identify associations between deviations from guideline‐concordant therapy and patient‐ and system‐level factors, and Cox regression models to assess risk of death.
Results
The cohort included 43 597 GC patients treated with endoscopic resection (8.9%), surgery only (47.1%), surgery and adjuvant therapy (20.6%), or NAT followed by surgery (23.5%). A total of 31 470 patients (72.2%) received guideline‐concordant therapy. Relative to Non‐Hispanic Whites (NHWs), Non‐Hispanic Blacks (NHBs) (odds ratio [OR] 1.19, [95% confidence intervals 1.10–1.28]) and Asian/Pacific Islanders (APIs) (OR 1.12 [1.03–1.23]) had an increased risk of deviations from treatment guidelines. Medicare/Medicaid increased the risk of deviations while treatment at high‐volume facilities decreased its risk for all races/ethnicities. Deviations from guidelines were associated with an increased risk of death (hazard ratio 1.56 [1.50–1.63].
Conclusions
Racial disparities in the delivery of guideline‐concordant therapy among GC patients are affected by several sociodemographic factors at the patient‐ and system‐level.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Section of Epidemiology and Population Sciences, Baylor College of Medicine, Houston, Texas, USA.
- Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA.
- Department of Medicine, Section of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, Texas, USA.
- Department of Surgery, Division of Surgical Oncology, Baylor College of Medicine, Houston, Texas, USA.
ORCID-Profile: Wilson L da Costa
Förderung
- NIDDK NIH HHS
- Research Training Awards from the Cancer Prevention & Research Institute of Texas for the Cancer Prevention Post-Graduate Training Program in Integrative Epide…
- Systems Epidemiology of Cancer Training Program (SECT)
Zitieren
APA
da Costa, W. L., Tan, M. C., Camp, E. R., & Thrift, A. P. (2024). Patient‐ and system‐level factors associated with racial/ethnic disparities in the delivery of guideline‐concordant therapy among US patients with gastric cancer. Journal of Surgical Oncology, 129(8), 1542-1553. https://doi.org/10.1002/jso.27683
Vancouver
da Costa WL, Tan MC, Camp ER, Thrift AP. Patient‐ and system‐level factors associated with racial/ethnic disparities in the delivery of guideline‐concordant therapy among US patients with gastric cancer. Journal of Surgical Oncology. 2024;129(8):1542-1553. doi:10.1002/jso.27683
BibTeX
@article{daCosta2024,
author = {da Costa, Wilson L and Tan, Mimi C and Camp, E Ramsay and Thrift, Aaron P},
title = {Patient‐ and system‐level factors associated with racial/ethnic disparities in the delivery of guideline‐concordant therapy among US patients with gastric cancer},
journal = {Journal of Surgical Oncology},
year = {2024},
volume = {129},
number = {8},
pages = {1542--1553},
doi = {10.1002/jso.27683}
}
EUVIMED